School of Pharmacy - News

The School of Pharmacy at the University of Eastern Finland and Cumulus Oncology have announced a new collaboration to facilitate early-stage cancer drug discovery.

The PhD study investigated cardiovascular drug use, statin discontinuation and coronary artery revascularization among persons with and without AD.

A new study discloses the discovery and application of a new therapeutic strategy to target the multidrug-resistant bacterium Salmonella enterica in vivo, with promising results.

The doctoral thesis is based on the nationwide register-based Finnish Parkinson’s disease study (FINPARK).

The awards ceremony was held on 20 December 2023 at Kuopio Campus.

Awards were presented to Project Researcher Ville Tahvanainen, UNITE Geotrail research project team, anniversary online communication of the School of Pharmacy, and Director of the Department of Health and Social Management Elsa Paronen.

Funding was granted from the Horizon Europe Programme to the NEMESIS project investigating the role of environmental chemicals as disrupters of normal human metabolism.

The University of Eastern Finland coordinates two funded Flagships, GeneCellNano and UNITE, and is a partner in the ACCC Flagship.

Bisphosphonates are commonly used to treat, for example, ostoporosis. One approach to mitigate their side effects is to utilize controlled delivery and release systems.

The results of the PhD study improve the understanding of molecular mechanisms underlying inflammasome activation in age-related macular degeneration and UV radiation-induced corneal inflammation.